Proteotype Diagnostics Ltd

About Proteotype Diagnostics Ltd

Proteotype Diagnostics focuses on illuminating critical points in a patient care journey through detection, prediction, and monitoring. Their mission is to predict treatment responses and monitor on-treatment responses using minimally invasive liquid biopsy techniques by profiling an individual's proteotype as a leading indicator of disease development.

Products & Services

Platform:A platform likely related to their diagnostic and monitoring technologies.

Enlighten:A product or service focused on providing insights or solutions in patient care, though specific details are not provided.

Specialties

Liquid Biopsy Proteotype Profiling Disease Detection Treatment Response Prediction On-Treatment Response Monitoring

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1500000 MR: - FA: £1.5 million FAN: 1500000	D: 2024-10-09 FD: 2024-10-09	2 investors

Grant Latest

2024-10-09

$1.5M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Wesley Sukdao

CEO & Chairman, Co-Founder

LinkedIn (Pro only)

D

Dr. Steven Walsh

Senior Scientist

D

Dr. Emma Yates

CSO & Co-Founder

LinkedIn (Pro only)

P

Patrícia Corredeira

Clinical Affairs

C

Chris Mewton

Principal Software Engineer

P

Prof. Gonçalo Bernardes

Co-Founder, Chair: Scientific Advisory Board

View 7 more team members with Pro

Unlock Full Team Directory

Recent News